444 related articles for article (PubMed ID: 11064832)
1. Community-acquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county.
Pedersen G; Schønheyder HC; Kristensen B; Sørensen HT
Dan Med Bull; 2000 Sep; 47(4):296-300. PubMed ID: 11064832
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
[TBL] [Abstract][Full Text] [Related]
3. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance patterns among blood culture isolates in a Danish county 1981-1995.
Kristensen B; Smedegaard HH; Pedersen HM; Andersen MF; Dahlerup JF; Sørensen HT; Korsager B; Schønheyder HC
J Med Microbiol; 1999 Jan; 48(1):67-71. PubMed ID: 9920127
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
Payerl-Pal M
Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
[TBL] [Abstract][Full Text] [Related]
7. Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia.
Pedersen G; Schønheyder HC; Steffensen FH; Sørensen HT
J Antimicrob Chemother; 1999 Jan; 43(1):119-26. PubMed ID: 10381109
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
9. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark.
Bukh AS; Schønheyder HC; Emmersen JM; Søgaard M; Bastholm S; Roslev P
J Antimicrob Chemother; 2009 Jul; 64(1):163-8. PubMed ID: 19429665
[TBL] [Abstract][Full Text] [Related]
13. [Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns].
Betriu C; Palau L; Gómez M; Sánchez A; Romero J; Picazo JJ
Rev Clin Esp; 1999 Aug; 199(8):503-10. PubMed ID: 10522430
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
[TBL] [Abstract][Full Text] [Related]
15. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
16. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs.
Berild D; Mohseni A; Diep LM; Jensenius M; Ringertz SH
J Antimicrob Chemother; 2006 Feb; 57(2):326-30. PubMed ID: 16387751
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic use and the prevalence of antibiotic resistance in bacteria from healthy volunteers in the dutch community.
Bruinsma N; Stobberingh E; de Smet P; van den Bogaard A
Infection; 2003 Jan; 31(1):9-14. PubMed ID: 12590326
[TBL] [Abstract][Full Text] [Related]
18. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
